Market Exclusive

AmerisourceBergen (NYSE:ABC) gets downgraded to Underperform by Bank of America with a price target of $76.00

Analyst Ratings For AmerisourceBergen (NYSE:ABC)

Today, AmerisourceBergen (NYSE:ABC) stock was downgraded by Bank of America from Buy to Underperform with a price target of $76.00.

There are 6 Hold Ratings, 1 Sell Ratings, 1 Buy Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on AmerisourceBergen (NYSE:ABC) is Hold with a consensus target price of $86.5714 per share, a potential 18.32% upside.

Some recent analyst ratings include

About AmerisourceBergen (NYSE:ABC)
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Recent Trading Activity for AmerisourceBergen (NYSE:ABC)
Shares of AmerisourceBergen closed the previous trading session at 73,59 −3,82 4,93 % with shares trading hands.

Exit mobile version